Macquarie Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-111
Closed -$1.85K 1946
2024
Q2
$1.85K Buy
+111
New +$1.85K ﹤0.01% 1810